Inogen Inc. (NASDAQ:INGN) shares fell to a low of $63.68 before closing at $64.76. Intraday shares traded counted 0.34 million, which was -116.12% lower than its 30-day average trading volume of 155.10K. INGN’s previous close was $65.83 while the outstanding shares total 22.18M. The firm has a beta of 0.90. The stock’s Relative Strength Index (RSI) is 53.76, with weekly volatility at 3.29% and ATR at 2.68. The INGN stock’s 52-week price range has touched low of $26.57 and a $69.00 high. The stock traded lower over the last trading session, losing -1.63% on 05/20/21.
Investors have identified the Medical Devices company Inogen Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $1.44 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Inogen Inc. (INGN) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 309.68 million total, with 55.47 million as their total liabilities.
INGN were able to record 1.34 million as free cash flow during the 08/10/2021 quarter of the year, this saw their quarterly net cash flow reduce by 8.05 million. In cash movements, the company had a total of 2.86 million as operating cash flow.
Potential earnings growth for Inogen Inc. (INGN)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/10/2021 quarter of the year, Inogen Inc. recorded a total of 86.93 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with -1.79% coming in sequential stages and their sales for the 08/10/2021 quarter increasing by 14.9%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 47.06 million trying to sell their products during the last quarter, with the result yielding a gross income of 39.87 million. This allows shareholders to hold on to 22.18M with the recently reported earning now reading -0.03 cents per share. This is a figure that compared to analyst’s prediction for their 08/10/2021 (-0.03 cents a share).
Having a look at the company’s valuation, the company is expected to record -0.29 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on INGN sounds very interesting.
Is the stock of INGN attractive?
In related news, EVP, Engineering, Taylor Brenton sold 2,841 shares of the company’s stock in a transaction that recorded on Apr 15. The sale was performed at an average price of 65.21, for a total value of 185,252. As the sale deal closes, the EVP, Finance, & CFO, Bauerlein Alison now sold 1,641 shares of the company’s stock, valued at 98,684. Also, EVP, Engineering, Taylor Brenton sold 6,104 shares of the company’s stock in a deal that was recorded on Apr 14. The shares were price at an average price of 60.22 per share, with a total market value of 367,587. Following this completion of acquisition, the EVP, Engineering, Taylor Brenton now holds 1,838 shares of the company’s stock, valued at 110,280. In the last 6 months, insiders have changed their ownership in shares of company stock by 13.20%.
1 out of 6 analysts covering the stock have rated it a Buy, while 4 have maintained a Hold recommendation on Inogen Inc.. 1 analysts has assigned a Sell rating on the INGN stock. The 12-month mean consensus price target for the company’s shares has been set at $58.67.